A post-doctoral fellow at the Stephenson Cancer Center at OU Medicine has received a highly competitive federal grant that will launch her research career focused on using mobile technology for tobacco cessation.
Emily Hébert, who holds a doctoral degree in public health, was awarded a K99 grant from the National Institute on Drug Abuse, part of the National Institutes of Health. She is completing her post-doctoral training at the Oklahoma Tobacco Research Center, a program of the Stephenson Cancer Center. Her research involves using smartphone technology to help people stop using tobacco.
The K99 grant plays a key role for researchers as they transition from post-doctoral training to junior faculty member. In order to establish an independent research program, post-doctoral fellows must conduct preliminary research, then use the data from those studies to apply for larger federal awards.
“The K99 award is a great opportunity,” Hébert said. “Most junior faculty are required to split their time across multiple projects and teaching. The K99 award guarantees that 75 percent of my time can be focused on my continued training and professional development, while I prepare and conduct a research study.”
Hébert’s research focuses on using smartphones to understand the triggers that make people want to smoke, in order to automatically deliver tailored messages in real time to try to prevent them from lighting a cigarette. Thus far, most smoking cessation interventions have been based on group-level patterns of smoking lapse – when people are feeling stress, for example, they are more likely to smoke. But Hébert’s aim is to develop a personalized algorithm that identifies each person’s smoking triggers and automatically delivers messages only when they are needed.
Hébert will spend the next two years exploring machine learning – the process by which computers use data to identify patterns. Through working with mentors on OU’s Norman campus and attending workshops and conferences, she will learn more about how machine learning can be integrated into her research. Her project involves sending short surveys via smartphones, several times a day, to research participants who want to stop smoking. Participants will be asked about their mood and environment, such as “Are you with any other smokers right now?” and “How strong is your craving to smoke?” The technology will then be used to “learn” how and when individuals are triggered to smoke.
“This research will help us to identify patterns in each smoker’s behavior, then an algorithm will be used to determine the types of messages that should be delivered, and when they should be delivered, to try to prevent someone from smoking,” Hébert said. “Understanding machine learning also will enable me to use data from other technology, such as a person’s heart rate from a smartwatch or activity monitor, to indicate when smoking relapse is imminent. I believe these methods could be used to help tailor interventions that address other cancer risk factors, like obesity and physical inactivity.”
During the second year of the grant, Hébert will begin interviewing for faculty positions. Once she secures a tenure-track faculty position, the next phase of her research career will begin: using machine learning to develop the actual smartphone-based smoking intervention.
Michael Businelle, Ph.D., Hébert’s primary mentor on the study, said her research is part of a growing field that leverages technology to study and intervene in health risk factors and behaviors.
“Dr. Hébert’s innovative project will contribute to this growing area of research while helping people to stop smoking and decrease their risk of developing cancer,” he said.
The work of Hébert and other researchers at the Oklahoma Tobacco Research Center is supported by the Oklahoma Tobacco Settlement Endowment Trust. An endowment created by state voters in 2000 to improve the health of Oklahomans, TSET is dedicated to reducing the state’s leading causes of preventable death – cancer and cardiovascular disease – caused by tobacco use and obesity.
STEPHENSON CANCER CENTER
The Stephenson Cancer Center is Oklahoma’s only National Cancer Institute-Designated Cancer Center. One of the nation’s elite centers, the Stephenson Cancer Center is the largest and most comprehensive oncology practice in the state, delivering patient-centered, multidisciplinary care for every type of cancer. As one of the nation’s leading research organizations, the Stephenson Cancer Center uses the latest innovations to fight and eliminate cancer, and is currently ranked No. 1 among all cancer centers in the nation for the number of patients participating in clinical trials sponsored by the NCI’s National Clinical Trials Network. For more information, visit stephensoncancercenter.org.
OU Medicine — along with its academic partner, the University of Oklahoma Health Sciences Center — is the state’s only comprehensive academic health system of hospitals, clinics and centers of excellence. With 11,000 employees and more than 1,300 physicians and advanced practice providers, OU Medicine is home to Oklahoma’s largest physician network with a complete range of specialty care. OU Medicine serves Oklahoma and the region with the state’s only freestanding children’s hospital, the only National Cancer Institute-Designated Stephenson Cancer Center and Oklahoma’s flagship hospital, which serves as the state’s only Level 1 trauma center. OU Medicine’s mission is to lead healthcare in patient care, education and research. To learn more, visit oumedicine.com.